Skip to main content
SpringerLink
Log in

Imaging Atherosclerotic Plaques with MRI: Role of Contrast Agents

  • Molecular Imaging (ZA Fayad, Section Editor)
  • Published:
Current Cardiovascular Imaging Reports Aims and scope Submit manuscript

Abstract

Magnetic resonance imaging (MRI) represents one of the most promising techniques for noninvasive evaluation of atherosclerotic plaques. During the last 10 years, acquisition techniques dedicated to vascular wall imaging have been developed for MRI and offer images with high spatial resolution atherosclerotic plaques in the aorta and carotid arteries. Major components of atherosclerotic plaques can be identified based on differences in their intrinsic contrast with MRI. In addition to morphologic aspects, detection of biological activities in atherosclerotic plaques with MRI could bring new hints for the identification of high-risk plaques. A large array of MR contrast agents has become available during the last 10 years and tested for the evaluation of atherosclerotic plaques. In this review, we will discuss the advantages and drawbacks of several classes of MR contrast agents developed for atherosclerotic plaque imaging using representative examples.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93:1354–63.

    Article  PubMed  CAS  Google Scholar 

  2. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108:1664–72.

    Article  PubMed  Google Scholar 

  3. Rioufol G, Finet G, Ginon I, Andre-Fouet X, Rossi R, Vialle E, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation. 2002;106:804–8.

    Article  PubMed  CAS  Google Scholar 

  4. Mauriello A, Sangiorgi G, Fratoni S, Palmieri G, Bonanno E, Anemona L, et al. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol. 2005;45:1585–93.

    Article  PubMed  Google Scholar 

  5. Fayad ZA, Nahar T, Fallon JT, Goldman M, Aguinaldo JG, Badimon JJ, et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation. 2000;101:2503–9.

    Article  PubMed  CAS  Google Scholar 

  6. Hatsukami TS, Ross R, Polissar NL, Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation. 2000;102:959–64.

    Article  PubMed  CAS  Google Scholar 

  7. Briley-Saebo KC, Mulder WJ, Mani V, Hyafil F, Amirbekian V, Aguinaldo JG, et al. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes. J Magn Reson Imaging. 2007;26:460–79.

    Article  PubMed  Google Scholar 

  8. Lipinski MJ, Fuster V, Fisher EA, Fayad ZA. Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging. Nat Clin Pract Cardiovasc Med. 2004;1:48–55.

    PubMed  CAS  Google Scholar 

  9. Corti R, Fuster V. Imaging of atherosclerosis: magnetic resonance imaging. Eur Heart J. 32:1709–19b.

  10. Fayad ZA, Fallon JT, Shinnar M, Wehrli S, Dansky HM, Poon M, et al. Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation. 1998;98:1541–7.

    Article  PubMed  CAS  Google Scholar 

  11. Fayad ZA, Fuster V, Fallon JT, Jayasundera T, Worthley SG, Helft G, et al. Noninvasive in Vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation. 2000;102:506–10.

    Article  PubMed  CAS  Google Scholar 

  12. Fayad ZA, Fuster V. Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann N Y Acad Sci. 2000;902:173–86.

    Article  PubMed  CAS  Google Scholar 

  13. Yuan C, Mitsumori LM, Beach KW, Maravilla KR. Carotid Atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology. 2001;221:285–99.

    Article  PubMed  CAS  Google Scholar 

  14. Yuan C, Mitsumori LM, Ferguson MS, Polissar NL, Echelard D, Ortiz G, et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation. 2001;104:2051–6.

    Article  PubMed  CAS  Google Scholar 

  15. Yuan C, Zhang SX, Polissar NL, Echelard D, Ortiz G, Davis JW, et al. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation. 2002;105:181–5.

    Article  PubMed  Google Scholar 

  16. Burke AP, Farb A, Malcom GT, Liang Y, Smialek JE, Virmani R. Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA. 1999;281:921–6.

    Article  PubMed  CAS  Google Scholar 

  17. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med. 2003;349:2316–25.

    Article  PubMed  CAS  Google Scholar 

  18. Chu B, Kampschulte A, Ferguson MS, Kerwin WS, Yarnykh VL, O'Brien KD, et al. Hemorrhage in the atherosclerotic carotid plaque: a high-resolution MRI study. Stroke. 2004;35:1079–84.

    Article  PubMed  Google Scholar 

  19. Takaya N, Yuan C, Chu B, Saam T, Polissar NL, Jarvik GP, et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation. 2005;111:2768–75.

    Article  PubMed  Google Scholar 

  20. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932–45.

    Article  PubMed  Google Scholar 

  21. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging. 2002;16:407–22.

    Article  PubMed  Google Scholar 

  22. Kerwin W, Hooker A, Spilker M, Vicini P, Ferguson M, Hatsukami T, et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation. 2003;107:851–6.

    Article  PubMed  Google Scholar 

  23. Dong L, Kerwin WS, Chen H, Chu B, Underhill HR, Neradilek MB, et al. Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum–evaluation by using dynamic contrast-enhanced MR imaging. Radiology. 260:224–31.

  24. Calcagno C, Cornily JC, Hyafil F, Rudd JH, Briley-Saebo KC, Mani V, et al. Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18 F-FDG PET. Arterioscler Thromb Vasc Biol. 2008;28:1311–7.

    Article  PubMed  CAS  Google Scholar 

  25. Calcagno C, Vucic E, Mani V, Goldschlager G, Fayad ZA. Reproducibility of black blood dynamic contrast-enhanced magnetic resonance imaging in aortic plaques of atherosclerotic rabbits. J Magn Reson Imaging. 32:191–8.

  26. •• Vucic E, Dickson SD, Calcagno C, Rudd JH, Moshier E, Hayashi K, et al. Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging. JACC Cardiovasc Imaging. 4:1100–9. This study showed that the anti-inflammatory effects of pioglitazone could be detected in atherosclerotic plaques using DCE-MRI in an experimental animal model.

  27. Lauffer RB, Parmelee DJ, Dunham SU, Ouellet HS, Dolan RP, Witte S, et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology. 1998;207:529–38.

    PubMed  CAS  Google Scholar 

  28. Port M, Meyer D, Bonnemain B, Corot C, Schaefer M, Rousseaux O, et al. P760 and P775: MRI contrast agents characterized by new pharmacokinetic properties. MAGMA. 1999;8:172–6.

    PubMed  CAS  Google Scholar 

  29. Paetsch I, Huber ME, Bornstedt A, Schnackenburg B, Boesiger P, Stuber M, et al. Improved three-dimensional free-breathing coronary magnetic resonance angiography using gadocoletic acid (B-22956) for intravascular contrast enhancement. J Magn Reson Imaging. 2004;20:288–93.

    Article  PubMed  Google Scholar 

  30. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493–503.

    Article  PubMed  CAS  Google Scholar 

  31. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002;90:251–62.

    PubMed  CAS  Google Scholar 

  32. Lancelot E, Amirbekian V, Brigger I, Raynaud JS, Ballet S, David C, et al. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arterioscler Thromb Vasc Biol. 2008;28:425–32.

    Article  PubMed  CAS  Google Scholar 

  33. Ouimet T, Lancelot E, Hyafil F, Rienzo M, Deux F, Lemaitre M, et al. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging. Mol Pharm. 9:850–61.

  34. Amirbekian V, Aguinaldo JG, Amirbekian S, Hyafil F, Vucic E, Sirol M, et al. Atherosclerosis and Matrix Metalloproteinases: experimental molecular MR imaging in vivo. Radiology. 2009.

  35. •• Hyafil F, Vucic E, Cornily JC, Sharma R, Amirbekian V, Blackwell F, et al. Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases. Eur Heart J. 2011;32:1561–71. This study demonstrated that molecular imaging with a small gadolinium-based MR contrast agent is feasible in atherosclerotic plaques.

    Article  PubMed  Google Scholar 

  36. Kimpe K, Parac-Vogt TN, Laurent S, Pierart C, Vander Elst L, Muller RN, et al. Potential MRI contrast agents based on micellar incorporation of amphiphilic bis(alkylamide) derivatives of [(Gd-DTPA)(H2O)](2-). Eur J Inorganic Chem. 2003;16:3021–7.

    Article  Google Scholar 

  37. Parac-Vogt TN, Kimpe K, Laurent S, Pierart C, Elst LV, Muller RN, et al. Gadolinium DTPA-monoamide complexes incorporated into mixed micelles as possible MRI contrast agents. Eur J Inorganic Chem. 2004;17:3538–43.

    Article  Google Scholar 

  38. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4:145–60.

    Article  PubMed  CAS  Google Scholar 

  39. Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation. 1996;94:3334–40.

    Article  PubMed  CAS  Google Scholar 

  40. Lanza GM, Winter P, Caruthers S, Schmeider A, Crowder K, Morawski A, et al. Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery. Curr Pharm Biotechnol. 2004;5:495–507.

    Article  PubMed  CAS  Google Scholar 

  41. Lanza GM, Abendschein DR, Yu X, Winter PM, Karukstis KK, Scott MJ, et al. Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technology. Acad Radiol. 2002;9 Suppl 2:S330–1.

    Article  PubMed  Google Scholar 

  42. Barkhausen J, Ebert W, Heyer C, Debatin JF, Weinmann HJ. Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging. Circulation. 2003;108:605–9.

    Article  PubMed  CAS  Google Scholar 

  43. Sirol M, Itskovich VV, Mani V, Aguinaldo JG, Fallon JT, Misselwitz B, et al. Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging. Circulation. 2004;109:2890–6.

    Article  PubMed  CAS  Google Scholar 

  44. Meding J, Urich M, Licha K, Reinhardt M, Misselwitz B, Fayad ZA, et al. Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with Gadofluorine M. Contrast Media Mol Imaging. 2007;2:120–9.

    Article  PubMed  CAS  Google Scholar 

  45. Briley-Saebo KC, Shaw PX, Mulder WJ, Choi SH, Vucic E, Aguinaldo JG, et al. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation. 2008;117:3206–15.

    Google Scholar 

  46. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation. 2001;103:1955–60.

    Article  PubMed  CAS  Google Scholar 

  47. Nishi K, Itabe H, Uno M, Kitazato KT, Horiguchi H, Shinno K, et al. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler Thromb Vasc Biol. 2002;22:1649–54.

    Article  PubMed  CAS  Google Scholar 

  48. Tsimikas S, Shortal BP, Witztum JL, Palinski W. In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression. Arterioscler Thromb Vasc Biol. 2000;20:689–97.

    Article  PubMed  CAS  Google Scholar 

  49. Briley-Saebo KC, Nguyen TH, Saeboe AM, Cho YS, Ryu SK, Volkova ER, et al. In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes. J Am Coll Cardiol. 2012;59:616–26.

    Article  PubMed  CAS  Google Scholar 

  50. Briley-Saebo KC, Cho YS, Shaw PX, Ryu SK, Mani V, Dickson S, et al. Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes. J Am Coll Cardiol. 2011;57:337–47.

    Article  PubMed  CAS  Google Scholar 

  51. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104:365–72.

    Article  PubMed  CAS  Google Scholar 

  52. von Zur Muhlen C, von Elverfeldt D, Bassler N, Neudorfer I, Steitz B, Petri-Fink A, et al. Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. Atherosclerosis. 2007;193:102–11.

    Article  Google Scholar 

  53. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol. 2004;39:56–63.

    Article  PubMed  CAS  Google Scholar 

  54. Litovsky S, Madjid M, Zarrabi A, Casscells SW, Willerson JT, Naghavi M. Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma. Circulation. 2003;107:1545–9.

    Article  PubMed  Google Scholar 

  55. Yancy AD, Olzinski AR, Hu TC, Lenhard SC, Aravindhan K, Gruver SM, et al. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling. J Magn Reson Imaging. 2005;21:432–42.

    Article  PubMed  Google Scholar 

  56. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation. 2001;103:415–22.

    Article  PubMed  CAS  Google Scholar 

  57. Hyafil F, Laissy JP, Mazighi M, Tchetche D, Louedec L, Adle-Biassette H, et al. Ferumoxtran-10-enhanced MRI of the hypercholesterolemic rabbit aorta: relationship between signal loss and macrophage infiltration. Arterioscler Thromb Vasc Biol. 2006;26:176–81.

    Article  PubMed  CAS  Google Scholar 

  58. •• Morris JB, Olzinski AR, Bernard RE, Aravindhan K, Mirabile RC, Boyce R, et al. p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment. Arterioscler Thromb Vasc Biol. 2008;28:265–71. This study demonstrates that imaging with USPIO can evidence biological effects of treatment, which would not have been identified based solely on histological analysis.

    Article  PubMed  CAS  Google Scholar 

  59. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M, et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation. 2003;107:2453–8.

    Article  PubMed  CAS  Google Scholar 

  60. Trivedi RA, Mallawarachi C, UK-I JM, Graves MJ, Horsley J, Goddard MJ, et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol. 2006;26:1601–6.

    Article  PubMed  CAS  Google Scholar 

  61. UK-I JM, Trivedi RA, Graves MJ, Cross JJ, Horsley J, Goddard MJ, et al. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke. 2004;35:1631–5.

    Article  Google Scholar 

  62. •• Tang TY, Howarth SP, Miller SR, Graves MJ, UK-I JM, Patterson AJ, et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol. 2009;53:2039–50. This imaging study evidenced that high-dose statin induced a stronger decrease of USPIO uptake in plaques assessed by MRI after 12 weeks of treatment compared with low-dose statin.

    Article  PubMed  CAS  Google Scholar 

  63. Rudd JH, Hyafil F, Fayad ZA. Inflammation imaging in atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1009–16.

    Article  PubMed  CAS  Google Scholar 

  64. Nahrendorf M, Jaffer FA, Kelly KA, Sosnovik DE, Aikawa E, Libby P, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation. 2006;114:1504–11.

    Article  PubMed  CAS  Google Scholar 

  65. Aime S, Castelli DD, Crich SG, Gianolio E, Terreno E. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. Acc Chem Res. 2009;42:822–31.

    Article  PubMed  CAS  Google Scholar 

  66. Terreno E, Castelli DD, Viale A, Aime S. Challenges for molecular magnetic resonance imaging. Chem Rev. 110:3019–42.

  67. Judenhofer MS, Wehrl HF, Newport DF, Catana C, Siegel SB, Becker M, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med. 2008;14:459–65.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Bichat University Hospital, Assistance Publique–Hôpitaux de Paris, Centre Hospitalier Universitaire Bichat, 46 rue Henri Huchard, 75018, Paris, France

    Fabien Hyafil & Dominique Le Guludec

  2. Inserm U698 Cardiovascular Bioengineering and University Paris Diderot-Paris 7, Paris, France

    Fabien Hyafil, Laurent Feldman & Dominique Le Guludec

  3. Department of Cardiology, Bichat University Hospital, Assistance Publique–Hôpitaux de Paris, Paris, France

    Laurent Feldman

  4. Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, New York, NY, 10029, USA

    Zahi A. Fayad

Authors
  1. Fabien Hyafil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laurent Feldman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zahi A. Fayad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dominique Le Guludec
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fabien Hyafil.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hyafil, F., Feldman, L., Fayad, Z.A. et al. Imaging Atherosclerotic Plaques with MRI: Role of Contrast Agents. Curr Cardiovasc Imaging Rep 6, 76–88 (2013). https://doi.org/10.1007/s12410-012-9179-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12410-012-9179-8

Keywords

Search

Navigation